IN order to investigate the effects of varying the rate of flow on endothelial integrity the rat isolated small intestinal vasculature was perfused at 1, 5, 10 or 20 ml/min with a gelatin-containing physiological salt solution (GPSS), followed by an injection of colloidal carbon suspension (CC). Significantly greater microvascular CC leakage occurred at 1 or 5 ml/min than at 10 or 20ml/ mitt. CC leakage at the two slower rates of flow was reduced by adding red blood cells to the GPSS, suggesting that the microvascular endotheHum became hypoxic when perfused with GPSS at 1 or 5 ml/min. After perfusion at 20ml/min with GPSS containing resiniferatoxin (1 gM) or 5-hydroxytryptamine (100 M), CC leakage was sicantly lower than after similar perfusion at 10ml/min. Two nitric oxide (NO) synthesis blockers, N-nitro-L-arginine methyl ester (L-NAME, 100M) and methylene blue (20M), and an NO scavenger CPTIO (100 M) each increased CC leakage. This suggests that NO was being produced at perfusion rates of 10 or 20 ml/min. Sodium nitroprusside (10 M), 8-bromo-cGMP (100 M) and BN52021 (10gM) each significantly reduced CC leakage in the presence of L-NAME.
Introduction
Colloidal carbon (CC) has been used routinely in this laboratory as a marker for assessing acute inflammatory responses to various compounds, in the microvasculature of rat small intestinal villi during perfusion in vitro. [1] [2] [3] [4] [5] However, small amounts of CC leak even in control preparations. Tissue hypoxia, due to the relatively low oxygencarrying capacity of the artificial perfusate being used, was one possible explanation. We now report the effect on CC leakage of varying the rate of perfusion and of increasing the oxygencarwing capacity of the perfusate by addition of pig washed red blood cells (RBCs) . The possibility that the endothelium might be producing an endogenous anti-inflammatory substance such as nitric oxide, particularly at higher rates of perfusion, has been investigated, along with possible associated alterations in the release of plateletactivating factor (PAF).
Materials and Methods
Perfusion of rat isolated mesentery and small intestine: The method used has been described 344 Mediators of Inflammation Vol 4 1995 in detail previously. Rats were killed by inhalation of chloroform vapour and the anterior mesenteric artery cannulated. The mesentery with the small intestine still attached was removed to a bath of gelatin-containing physiological salt solution (GPSS) with RBCs added where appropriate (GPSS + RBC) at 37C. Rat blood was flushed from the vasculature using 50 ml of either GPSS or GPSS + RBC delivered at a rate of 10 Possible involvement of NO: Figure 1 shows that L-NAME (100l.tM), an antagonist of NO production, 6 increased CC leakage in microvessels perfused with GPSS at 5, 10 or 20 ml/min. At 20 aResults (mm Hg) are given as mean -t-S.E.M. b20% V/V RBC added at and 5 ml/min, but 10% v/v RBC at 10 and 20 ml/min. Cp < 0.05, dp < 0.005 (Bonferroni's test) compared with PP change using GPSS alone at the same flow rate. 10 and 20 ml/min. (Fig. 1) . In the absence of L-NAME, BN52021 had no effect on CC leakage. Thus, PAF appeared not to be involved when NO synthase was still operational, but may have been involved in the absence of NO.
Discussion
The reduced CC leakage found in response to the addition of either RFX or 5HT at a perfusion rate of 20ml/min, compared with that seen at 10ml/min, suggested that at the higher rate of flow an endothelial cell (EC) protectant substance was being released in greater than normal amounts, or that at the lower rate of flow a leakage-promoting substance was being released. Several workers have suggested that endotheliumderived relaxant factor (EDRF), which is probably NO, 7 is released in greater than normal amounts at high rates of vascular flow 4'5 or wall 16.17 shear stress.
Administration of L-NAME n our experiments was an attempt to inhibit endogenous NO production. However, the resultant increase in CC leakage was similar at 5, 10 and 20ml/min, suggesting that even at 5 ml/min NO secretion was occurring. Hence the difference between responses seen in the present experiments at 10 and 20ml/min more likely was due to reduced production of a leakage-promoting substance at the higher rate of flow than to some variation in the rate of NO production. PAF is known to be generated by ECs in the presence but not in the absence of L-NAME. 21 In the present experiments pre-treatment with the PAF inhibitor BN52021 inhibited CC leakage induced by L-NAME, but in the absence of L-NAME the same concentration of BN52021 failed to reduce CC leakage (Fig. 1) 
